Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03734536 · ClinicalTrials.gov registry record · NA
Treatment of Partial-Thickness Rotator Cuff Tears
A NA study, sponsored by Smith & Nephew.
- Terminated
- Registry status
- NA
- Development phase
- 168
- Enrollment target
NCT03734536 is a NA study that was terminated before completion, run by Smith & Nephew. The registered enrollment target is 168 participants.
The verdict
NCT03734536, a NA study, was terminated before completion, sponsored by Smith & Nephew.
- TERMINATED
- Registry status
- NA
- Development phase
- 168 participants
- Enrollment target
Study Summary
The goal of this clinical trial is to demonstrate that REGENETEN is superior to standard repair techniques when surgically treating high-grade (\>50%) partial-thickness tears.
Interventions
- DEVICE REGENETEN™ Bioinductive Implant
- DEVICE Arthroscopic repair of the high-grade (>50%) partial-thickness
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 168 participants |
| Start Date | 2018-12-05 |
| Est. Completion | 2023-09-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03734536
The ClinicalTrials.gov registry entry for NCT03734536 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 168 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Smith & Nephew, which has 72 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which REGENETEN™ Bioinductive Implant is the first listed.
NCT03734536 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03734536 about?
NCT03734536 is a clinical study titled "Treatment of Partial-Thickness Rotator Cuff Tears". The goal of this clinical trial is to demonstrate that REGENETEN is superior to standard repair techniques when surgically treating high-grade (\>50%) partial-thickness tears.
What is the current status of trial NCT03734536?
This trial is currently terminated. It is a NA study. The enrollment target is 168 participants. The study started on 2018-12-05. Estimated completion is 2023-09-11.
What interventions are being tested in trial NCT03734536?
The interventions under investigation include: REGENETEN™ Bioinductive Implant (DEVICE), Arthroscopic repair of the high-grade (>50%) partial-thickness (DEVICE).
Who is sponsoring clinical trial NCT03734536?
This trial is sponsored by Smith & Nephew, which has 72 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.